These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 31831121)

  • 21. Vascular Calcification: An Important Understanding in Nephrology.
    Zununi Vahed S; Mostafavi S; Hosseiniyan Khatibi SM; Shoja MM; Ardalan M
    Vasc Health Risk Manag; 2020; 16():167-180. PubMed ID: 32494148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updates on the Mechanisms and the Care of Cardiovascular Calcification in Chronic Kidney Disease.
    Hénaut L; Chillon JM; Kamel S; Massy ZA
    Semin Nephrol; 2018 May; 38(3):233-250. PubMed ID: 29753400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbamylated Proteins in Renal Disease: Aggravating Factors or Just Biomarkers?
    Gorisse L; Jaisson S; Piétrement C; Gillery P
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
    Yamada S; Tatsumoto N; Tokumoto M; Noguchi H; Ooboshi H; Kitazono T; Tsuruya K
    Calcif Tissue Int; 2015 Apr; 96(4):347-58. PubMed ID: 25511229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship?
    Schwedler S; Schinzel R; Vaith P; Wanner C
    Kidney Int Suppl; 2001 Feb; 78():S32-6. PubMed ID: 11168979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-translational modifications in kidney diseases and associated cardiovascular risk.
    Noels H; Jankowski V; Schunk SJ; Vanholder R; Kalim S; Jankowski J
    Nat Rev Nephrol; 2024 Aug; 20(8):495-512. PubMed ID: 38664592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sortilin, carbamylation, and cardiovascular calcification in chronic kidney disease.
    Massy ZA; Liabeuf S
    Kidney Int; 2022 Mar; 101(3):456-459. PubMed ID: 35190032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury.
    Rungratanawanich W; Qu Y; Wang X; Essa MM; Song BJ
    Exp Mol Med; 2021 Feb; 53(2):168-188. PubMed ID: 33568752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
    Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.
    Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactive carbonyl compounds related uremic toxicity ("carbonyl stress").
    Miyata T; Sugiyama S; Saito A; Kurokawa K
    Kidney Int Suppl; 2001 Feb; 78():S25-31. PubMed ID: 11168978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of aldosterone in uremic vascular calcification in patient with end-stage renal disease].
    Yan TK; Jia JY; Lin S
    Sheng Li Ke Xue Jin Zhan; 2010 Oct; 41(5):383-6. PubMed ID: 21416933
    [No Abstract]   [Full Text] [Related]  

  • 33. Protein carbamylation: a key driver of vascular calcification during chronic kidney disease.
    Hawkins CL
    Kidney Int; 2018 Jul; 94(1):12-14. PubMed ID: 29933841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced glycation end products promote meniscal calcification by activating the mTOR-ATF4 positive feedback loop.
    Yang S; Xie J; Pan Z; Guan H; Tu Y; Ye Y; Huang S; Fu S; Li K; Huang Z; Li X; Shi Z; Li L; Zhang Y
    Exp Mol Med; 2024 Mar; 56(3):630-645. PubMed ID: 38424194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological Role of Advanced Glycation End Products (AGEs) and their Receptor Axis in Atrial Fibrillation.
    Yamagishi SI; Sotokawauchi A; Matsui T
    Mini Rev Med Chem; 2019; 19(13):1040-1048. PubMed ID: 30854960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression.
    Belmokhtar K; Ortillon J; Jaisson S; Massy ZA; Boulagnon Rombi C; Doué M; Maurice P; Fritz G; Gillery P; Schmidt AM; Rieu P; Touré F
    Nephrol Dial Transplant; 2019 Dec; 34(12):2018-2030. PubMed ID: 30778553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein Carbamylation in Chronic Kidney Disease and Dialysis.
    Long J; Vela Parada X; Kalim S
    Adv Clin Chem; 2018; 87():37-67. PubMed ID: 30342712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?
    Zhuang A; Forbes JM
    Glycoconj J; 2016 Aug; 33(4):645-52. PubMed ID: 27270766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced glycation end products in uremia.
    Henle T; Miyata T
    Adv Ren Replace Ther; 2003 Oct; 10(4):321-31. PubMed ID: 14681861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes.
    Yang P; Feng J; Peng Q; Liu X; Fan Z
    Oxid Med Cell Longev; 2019; 2019():9570616. PubMed ID: 31885827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.